Company intelligence / Profile preview

Cyprotex

Macclesfield / Alderley Park, England, United Kingdomevotec.com ↗

Ownership: Private
Development stage: Other

Overview

Cyprotex is an industry-leading contract research organization specializing in predictive toxicology and ADME-PK/ADME-Tox services. They support pharmaceutical, biotech, chemical, cosmetics/personal care industries with high-throughput screening, customized assays, mechanistic toxicology studies (including transcriptomics and 3D models), safety screening for discovery projects through clinical development stages. The company was acquired by Evotec in 2016 and operates as part of the Evotec Group.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on Cyprotex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyprotex.

Explore the full profile